Suppr超能文献

滤泡树突状细胞诱导的 microRNA 介导的非霍奇金 B 细胞淋巴瘤中 PRDM1 的上调和 BCL-6 的下调。

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas.

机构信息

Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33613, USA.

出版信息

Leukemia. 2011 Jan;25(1):145-52. doi: 10.1038/leu.2010.230. Epub 2010 Oct 22.

Abstract

B-cell lymphoma 6 (BCL6) and PR domain containing 1 (PRDM1) are considered as master regulators for germinal center (GC) formation and terminal B-cell differentiation. Dysregulation of BCL6 and PRDM1 has been associated with lymphomagenesis. Here, we show for the first time that direct cell-cell contact between follicular dendritic cells (FDC) and B-lymphocytes, by influencing the expression of a set of microRNAs (miRNAs), regulates the expression of BCL6 and PRDM1. We identify that, on cell adhesion to FDC, FDC induces upregulation of PRDM1 expression through downregulation of miR-9 and let-7 families and induces downregulation of BCL-6 through upregulation of miR-30 family in B-lymphocytes and lymphoma cells. We further demonstrate that the miR-30 family directly controls BCL-6 expression and miR-9-1 and let-7a directly control PRDM-1 expression through targeting their 3'UTR, mediating the FDC effect. Our studies define a novel regulatory mechanism in which the FDC, through induction of miRNAs in B-lymphocytes, orchestrates the regulation of transcription factors, promotes germinal center B-cell survival and differentiation. Dysregulation of miRNAs may interfere with B-cell survival and maturation, thus representing a novel molecular mechanism, as well as a potential therapeutic target in B-cell lymphomas.

摘要

B 细胞淋巴瘤 6(BCL6)和 PR 结构域包含 1(PRDM1)被认为是生发中心(GC)形成和终末 B 细胞分化的主要调节因子。BCL6 和 PRDM1 的失调与淋巴瘤的发生有关。在这里,我们首次表明,滤泡树突状细胞(FDC)与 B 淋巴细胞之间的直接细胞-细胞接触通过影响一组 microRNAs(miRNAs)的表达来调节 BCL6 和 PRDM1 的表达。我们发现,在细胞黏附到 FDC 上时,FDC 通过下调 miR-9 和 let-7 家族来诱导 PRDM1 表达上调,并通过上调 miR-30 家族在 B 淋巴细胞和淋巴瘤细胞中诱导 BCL-6 下调。我们进一步证明,miR-30 家族通过靶向其 3'UTR 直接控制 BCL-6 的表达,miR-9-1 和 let-7a 通过靶向其 3'UTR 直接控制 PRDM-1 的表达,介导 FDC 的作用。我们的研究定义了一种新的调节机制,其中 FDC 通过诱导 B 淋巴细胞中的 miRNAs,协调转录因子的调节,促进生发中心 B 细胞的存活和分化。miRNAs 的失调可能会干扰 B 细胞的存活和成熟,因此代表了一种新的分子机制,以及 B 细胞淋巴瘤的潜在治疗靶点。

相似文献

引用本文的文献

2
MicroRNA-regulated B cells in obesity.肥胖中受微小RNA调控的B细胞。
Immunometabolism (Cobham). 2022 Aug 5;4(3):e00005. doi: 10.1097/IN9.0000000000000005. eCollection 2022 Jul.
4
CAM-DR: Mechanisms, Roles and Clinical Application in Tumors.CAM-DR:肿瘤中的机制、作用及临床应用
Front Cell Dev Biol. 2021 Jul 6;9:698047. doi: 10.3389/fcell.2021.698047. eCollection 2021.
9
The Role of Noncoding RNAs in B-Cell Lymphoma.非编码RNA在B细胞淋巴瘤中的作用。
Front Oncol. 2020 Oct 23;10:577890. doi: 10.3389/fonc.2020.577890. eCollection 2020.

本文引用的文献

2
Identification of the human mature B cell miRNome.人类成熟B细胞微小RNA组的鉴定。
Immunity. 2009 May;30(5):744-52. doi: 10.1016/j.immuni.2009.03.017. Epub 2009 May 14.
4
MiRNAs and cancer.微小RNA与癌症。
Am J Pathol. 2009 Apr;174(4):1131-8. doi: 10.2353/ajpath.2009.080794. Epub 2009 Mar 5.
6
MicroRNAs in the ontogeny of leukemias and lymphomas.白血病和淋巴瘤发生过程中的微小RNA
Leuk Lymphoma. 2009 Feb;50(2):160-70. doi: 10.1080/10428190802535114.
9
MicroRNAs and lymphomas.微小RNA与淋巴瘤
Ann Oncol. 2008 Jun;19 Suppl 4:iv39-40. doi: 10.1093/annonc/mdn192.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验